COVID-19 Vaccinations April 21, 2020
What is Going on With the Coronavirus?
The different coronavirus types have been around for the past 50+ years, where a significant amount of research has already been done. Discovering how a coronavirus develops and replicates has led to blending human with veterinary science, as the virus is known to infect both humans and animals. It is also known that each coronavirus type may target and replicate in different parts of the body. As is known, CoVid19 SARS virus primarily targets the human respiratory tract.
As viruses mutate and produce different types of viruses, new tests to determine the type of virus have to be developed. Test development and standardization in itself, takes a minimum of 7-8 months to a few years in some cases, to be sensitive and specific enough to determine a reliable, accurate test result. Without rigorous and repeated test trials over time, an increased potential for false positive results will be found. Currently, not enough time has been taken to accurately develop a test specific for coronavirus 19. More than likely, other types of the coronavirus are being detected and reported as CoVid19, leading to an inflated actual number of true Covid19 SARS cases.
Inflated numbers or not, science is moving forward with a focus on vaccine development. The information below is to create awareness. According to the Johns Hopkins Center for Health Security, April 21, 2020 online Report:
By Divya Hosangadi, Kelsey Lane Warmbrod, Elena K Martina, Amesh Adalja, Anita Cicero, Thomas Inglesby, Crystal Watson, Matthew Watson, Nancy Connell
The global reach of infectious disease pandemics typically necessitates a similarly ubiquitous public health intervention: mass vaccination. The development and large-scale deployment of a vaccine requires substantial investment and a coalition of stakeholders to undertake research and development (including phase I to III clinical trials), manufacturing, and widespread administration.”
On another note, from the April 21, 2020 Johns Hopkins report:
“WHO warns that few have developed antibodies to Covid-19 (The Guardian) Only a tiny proportion of the global population – maybe as few as 2% or 3% – appear to have antibodies in the blood showing they have been infected with Covid-19, according to the World Health Organization, a finding that bodes ill for hopes that herd immunity will ease the exit from lockdown.”
For more information regarding vaccination updates or other SARS CoVid19 information, visit Johns Hopkins Center for Health Security <hsheadlines@jhu.edu or any other major medical research facility.